Evidence-Based Medicine Guidelines
Tiotropium versus ipratropium for COPD
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tiotropium Versus Ipratropium for COPD." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458246/all/Tiotropium_versus_ipratropium_for_COPD.
Tiotropium versus ipratropium for COPD. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/458246/all/Tiotropium_versus_ipratropium_for_COPD. Accessed May 11, 2025.
Tiotropium versus ipratropium for COPD. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/458246/all/Tiotropium_versus_ipratropium_for_COPD
Tiotropium Versus Ipratropium for COPD [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 May 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458246/all/Tiotropium_versus_ipratropium_for_COPD.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tiotropium versus ipratropium for COPD
ID - 458246
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458246/all/Tiotropium_versus_ipratropium_for_COPD
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
